AR and nonpapillary renal cell carcinoma: AR splice variant expression (AR-V1, AR-V3, AR-V4, AR-V7, and AR-V12) was investigated using primary ccRCC and pRCC tumors, focusing on AR splice variants that are constitutively active [152].